IBEX Ltd (IBEX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
IBEX Ltd stock (IBEX) is currently trading at $26.79. IBEX Ltd PE ratio is 9.31. IBEX Ltd PS ratio (Price-to-Sales) is 0.63. Analyst consensus price target for IBEX is $41.00. WallStSmart rates IBEX as Hold.
- IBEX PE ratio analysis and historical PE chart
- IBEX PS ratio (Price-to-Sales) history and trend
- IBEX intrinsic value — DCF, Graham Number, EPV models
- IBEX stock price prediction 2025 2026 2027 2028 2029 2030
- IBEX fair value vs current price
- IBEX insider transactions and insider buying
- Is IBEX undervalued or overvalued?
- IBEX Ltd financial analysis — revenue, earnings, cash flow
- IBEX Piotroski F-Score and Altman Z-Score
- IBEX analyst price target and Smart Rating
IBEX
📊 No data available
Try selecting a different time range
IBEX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · IBEX Ltd (IBEX)
IBEX trades at a significant discount to its Graham intrinsic value of $140.87, offering a 79% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
IBEX Ltd (IBEX) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in return on equity, price/sales, eps growth. Concerns around operating margin. Fundamentals are solid but monitor weak areas for improvement.
IBEX Ltd (IBEX) Key Strengths (4)
Every $100 of shareholder equity generates $34 in profit
Paying less than $1 for every $1 of annual revenue
Earnings per share surging 45.60% year-over-year
96.55% of shares held by major funds and institutions
Supporting Valuation Data
IBEX Ltd (IBEX) Areas to Watch (5)
Very thin margins with limited operational efficiency
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Fairly priced relative to book value
Solid revenue growth at 16.70% per year
IBEX Ltd (IBEX) Detailed Analysis Report
Overall Assessment
This company scores 63/100 in our Smart Analysis, earning a C+ grade. Out of 9 metrics analyzed, 4 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 4.6/10). All four categories (Growth, Profitability, Valuation, and Quality) show healthy scores, indicating broadly sound fundamentals.
The Bull Case
The strongest argument centers on Return on Equity, Price/Sales, EPS Growth. Valuation metrics including Price/Sales (0.63) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 33.70%. Growth metrics are encouraging with EPS Growth at 45.60%.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Market Cap. Some valuation metrics including Price/Book (2.43) suggest expensive pricing. Growth concerns include Revenue Growth at 16.70%, which may limit upside. Profitability pressure is visible in Operating Margin at 9.31%, Profit Margin at 7.35%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 33.70% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 16.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Return on Equity, Price/Sales) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
IBEX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
IBEX's Price-to-Sales ratio of 0.63x sits near its historical average of 0.65x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 8% below its historical high of 0.68x set in Mar 2026, and -1% above its historical low of 0.63x in Mar 2026.
Compare IBEX with Competitors
Top INFORMATION TECHNOLOGY SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for IBEX Ltd (IBEX) · TECHNOLOGY › INFORMATION TECHNOLOGY SERVICES
The Big Picture
IBEX Ltd is a strong growth company balancing expansion with improving profitability. Revenue reached 603M with 17% growth year-over-year. Profit margins are thin at 7.3%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 3370.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Free cash flow is -5M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Margin expansion: can IBEX Ltd push profit margins above 15% as the business scales?
Debt management: total debt of 64M is significantly higher than cash (15M). Monitor refinancing risk.
Sector dynamics: monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive moves, and regulatory changes that could impact IBEX Ltd.
Bottom Line
IBEX Ltd offers an attractive blend of growth (17% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(39 last 3 months)
| Insider | Type | Shares |
|---|---|---|
DARWAL, MICHAEL JOSEPH Chief AI & Digital Officer | Sell | -925 |
| Insider | Type | Shares |
|---|---|---|
DECHANT, ROBERT THOMAS Director, Chief Executive Officer | Sell | -6,000 |
| Insider | Type | Shares |
|---|---|---|
DECHANT, ROBERT THOMAS Director, Chief Executive Officer | Sell | -6,000 |
| Insider | Type | Shares |
|---|---|---|
DECHANT, ROBERT THOMAS Director, Chief Executive Officer | Sell | -6,000 |
| Insider | Type | Shares |
|---|---|---|
DECHANT, ROBERT THOMAS Director, Chief Executive Officer | Sell | -6,000 |
| Insider | Type | Shares |
|---|---|---|
DECHANT, ROBERT THOMAS Director, Chief Executive Officer | Sell | -6,000 |
| Insider | Type | Shares |
|---|---|---|
DARWAL, MICHAEL JOSEPH Chief AI & Digital Officer | Buy | +25,000 |
Data sourced from SEC Form 4 filings
Last updated: 8:21:35 AM
About IBEX Ltd(IBEX)
NASDAQ
TECHNOLOGY
INFORMATION TECHNOLOGY SERVICE...
USA
IBEX Limited provides comprehensive technology-enabled customer lifecycle experience solutions in the United States and internationally.